Noom Med vs Willow: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher & Publisher

Reviewed & updated August 14, 2026 · Cites primary sources (FDA, NEJM, CMS) · Not medical advice

54 providers verified independently·Independent research·How we rank →

Short answer: Willow scores higher on our rubric, 7.5/10 against 7.4/10. Full reasoning, pricing and the cases where the other one wins are below.

Visit Embody - our featured pick →or find your match

Willow beats Noom Med overall, scoring 7.5/10 vs 7.4/10. Published pricing is not a like-for-like monthly comparison: Noom Med is $79 first month, then $199/mo; Willow is from $299/mo. Choose Noom Med for users who want a low-dose glp-1 with biomarker monitoring and can absorb the step from a $79 starter to $199/mo ongoing. Choose Willow for users who want comprehensive clinical support with flexibility between injectable and oral compounded semaglutide routes.

A side-by-side look at Noom Med and Willow to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

Noom Med

#23 of 54

7.4/10

Noom restructured Noom Med in 2026 into a GLP-1 ladder plus a non-GLP-1 pill: Microdose GLP-1Rx at $79 then $199/mo, GLP-1Rx at $129 then $249/mo, GLP-1Rx Plus at $149 then $299/mo, and a metformin pill at $69 then $99/mo that is not a GLP-1. Verified 2026-07-27. Historic note: the Full GLP-1Rx program ($149 intro → $349/mo on 12-week subscription). Coaching app included at every tier.

Visit Noom Med

Higher Rated

Willow

#20 of 54

7.5/10

Personalized GLP-1 weight loss with ongoing clinical support. Compounded semaglutide and tirzepatide only, Willow explicitly does not prescribe brand-name Wegovy or Zepbound. Added oral compounded semaglutide tablets as a non-injectable option.

Visit Willow

Feature	Noom Med	Willow
Why each one	The only GLP-1 platform built on a decade of behavioral psychology research, combining medication with Noom's proven coaching methodology for lasting habit change.	One of the few compounded-only platforms offering both injectable and daily oral semaglutide tablets, useful for users who want a non-injectable option without leaving the GLP-1 compounded category.
Our Score	7.4/10	7.5/10
Headline Price	$79 first month, then $199/mo	from $299/mo
Medication Type	Both	Compounded
Insurance Accepted	Yes	No
Best For	Users who want a low-dose GLP-1 with biomarker monitoring and can absorb the step from a $79 starter to $199/mo ongoing	Users who want comprehensive clinical support with flexibility between injectable and oral compounded semaglutide routes
Watch out for	Tiered pricing is genuinely confusing, and the cheapest advertised tier ($69 then $99/mo) is metformin rather than a GLP-1, which is easy to mistake for the GLP-1 entry price [Verified 2026-07-27]	Compounded-only, no brand-name Wegovy or Zepbound through the platform
Ranking	#23	#20
Get started	Visit Noom Med	Visit Willow

Pros & Cons Compared

Noom Med

Pros

+Tiered 2026 entry, $69/mo branded telehealth tier lets users start with just medication access and the coaching app
+Microdose GLP-1Rx is $79 for the first 4 weeks then $199/mo billed quarterly, low-dose GLP-1 plus biomarker monitoring for side-effect-sensitive users [Verified 2026-07-27]
+Insurance accepted for qualifying plans, can significantly reduce out-of-pocket costs on brand-name meds
+Industry-leading behavioral coaching app with years of psychology-based weight loss methodology

Cons

−Tiered pricing is genuinely confusing, and the cheapest advertised tier ($69 then $99/mo) is metformin rather than a GLP-1, which is easy to mistake for the GLP-1 entry price [Verified 2026-07-27]
−Full GLP-1Rx program requires 12-week subscription ($149 intro rate applies only for the first few weeks)
−Medication costs on the $69 tier are out-of-pocket, the low tier price is just the platform
−App coaching still requires real engagement, skip-prone users waste the behavioral value

Willow

Pros

+Includes monthly provider check-ins and dose adjustments at no extra cost
+Offers both injectable AND oral compounded semaglutide, one of few platforms with a daily oral tablet option
+$299/mo all-in for compounded semaglutide with monthly provider support
+90%+ patient retention rate after 3 months per their published outcomes data

Cons

−Compounded-only, no brand-name Wegovy or Zepbound through the platform
−Tirzepatide pricing reaches $499-$524 at higher doses, starting dose is $399/mo
−Cash-pay only, no insurance billing, though they provide superbills for FSA/HSA
−Founded in 2024, less track record than Ro or Hims, though growth has been fast

Our Verdict

Willow edges out Noom Med with a score of 7.5/10 vs 7.4/10. Published pricing is not a like-for-like monthly comparison: Noom Med is $79 first month, then $199/mo; Willow is from $299/mo. Noom Med accepts insurance, which can significantly reduce your out-of-pocket costs. Noom Med offers both brand-name and compounded medications, giving you more flexibility.